{"id": "1356954340074819590", "creation": 1612358100.0, "user_id": "60017224", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "The companies aim to have a candidate approved by 2022 as part of a 150 million euro ($180 million) deal... #Glaxo #CureVac #Covid19 #Vaccine \nhttps://t.co/8Nl1akdrXt", "first_save": 1634559108.199414, "hashtags": ["#GLAXO", "#CUREVAC", "#COVID19", "#VACCINE"]}